Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 360 entries
View as:

A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures

Phase: N/A Priority: Normal
NCT ID: NCT00209560 Org: User:
Start: 10/31/04 End: 03/31/05 Due: 03/31/06

An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00280397 Org: User:
Start: 01/31/06 End: 11/30/08 Due: 11/30/09

To Assess the Effect of Lorcaserin Hydrochloride on Energy Metabolism and Food Intake

Phase: N/A Priority: Normal
NCT ID: NCT00829140 Org: User:
Start: 11/30/08 End: 02/28/10 Due: 02/28/11

Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil

Phase: N/A Priority: Normal
NCT ID: NCT03533361 Org: User:
Start: - End: - Due: -

A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy

Phase: N/A Priority: Normal
NCT ID: NCT00209586 Org: User:
Start: 09/30/04 End: 03/31/05 Due: 03/31/06

Study to Evaluate the Respiratory Safety of Lemborexant in Adult and Elderly Healthy Subjects and Adult and Elderly Subjects With Mild Obstructive Sleep Apnea

Phase: N/A Priority: Normal
NCT ID: NCT03471871 Org: User:
Start: 02/21/18 End: 08/03/18 Due: 08/03/19

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00658528 Org: User:
Start: 02/29/08 End: 01/31/10 Due: 01/31/11

A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Phase: N/A Priority: Normal
NCT ID: NCT04109092 Org: User:
Start: 02/13/20 End: 09/29/22 Due: 09/29/23

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

Phase: N/A Priority: Normal
NCT ID: NCT01527006 Org: User:
Start: 01/31/12 End: 04/30/15 Due: 04/30/16

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

Phase: N/A Priority: Normal
NCT ID: NCT00571064 Org: User:
Start: 01/31/08 End: 04/22/09 Due: 04/22/10

A Trial of Lenvatinib (E7080) in Subjects With Iodine-131 Refractory Differentiated Thyroid Cancer to Evaluate Whether an Oral Starting Dose of 18 Milligram (mg) Daily Will Provide Comparable Efficacy to a 24 mg Starting Dose, But Have a Better Safety Profile

Phase: N/A Priority: Normal
NCT ID: NCT02702388 Org: User:
Start: 06/08/17 End: 09/10/20 Due: 09/10/21

Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology

Phase: N/A Priority: Normal
NCT ID: NCT00784303 Org: User:
Start: 11/06/08 End: 03/29/19 Due: 03/29/20

A Study to Evaluate the Pharmacodynamic Activity of E2082 in Adult Participants With Photosensitive Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03686033 Org: User:
Start: 10/31/18 End: 06/18/19 Due: 06/18/20

Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

Phase: N/A Priority: Normal
NCT ID: NCT00368108 Org: User:
Start: 08/31/06 End: 01/31/08 Due: 01/31/09

A Study of E2086 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT06481488 Org: User:
Start: 06/25/24 End: 12/13/24 Due: 12/13/25

Study of Lenvatinib in Subjects With Advanced Endometrial Cancer and Disease Progression

Phase: N/A Priority: Normal
NCT ID: NCT01111461 Org: User:
Start: 03/31/10 End: 10/31/15 Due: 10/31/16

A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00879086 Org: User:
Start: 03/31/09 End: 04/30/14 Due: 04/30/15

Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies

Phase: N/A Priority: Normal
NCT ID: NCT03467152 Org: User:
Start: 05/04/18 End: 04/15/20 Due: 04/15/21

Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02481050 Org: User:
Start: 06/16/15 End: 09/05/17 Due: 09/05/18

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

Phase: N/A Priority: Normal
NCT ID: NCT00934375 Org: User:
Start: 02/28/06 End: 09/30/07 Due: 09/30/08

Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole

Phase: N/A Priority: Normal
NCT ID: NCT00132496 Org: User:
Start: 08/31/05 End: 07/31/06 Due: 07/31/07

Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)

Phase: N/A Priority: Normal
NCT ID: NCT01600859 Org: User:
Start: 07/31/12 End: 10/31/13 Due: 10/31/14

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2609 in Healthy Subjects and an Elderly Cohort

Phase: N/A Priority: Normal
NCT ID: NCT01294540 Org: User:
Start: 12/31/10 End: 12/31/11 Due: 12/31/12

Demonstrate Bioequivalence Between 6 ? 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01396590 Org: User:
Start: 12/31/10 End: 03/31/11 Due: 03/31/12

E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125

Phase: N/A Priority: Normal
NCT ID: NCT01133756 Org: User:
Start: 03/31/10 End: 09/30/12 Due: 09/30/13